Cargando…
Use of Monoclonal Antibodies in Pregnant Women Infected by COVID-19: A Case Series
Background: Monoclonal antibodies are designed to target specific proteins of COVID-19 and can be used as a treatment for people with mild to moderate infection and at a high risk of severe disease. Casirivimab/imdevimab, sotrovimab, and Bamlanivimab/etesevimab have been authorized for emergency use...
Autores principales: | Crispino, Pietro, Marocco, Raffaella, Di Trento, Daniela, Guarisco, Gloria, Kertusha, Blerta, Carraro, Anna, Corazza, Sara, Pane, Cristina, Di Troia, Luciano, del Borgo, Cosimo, Lichtner, Miriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459383/ https://www.ncbi.nlm.nih.gov/pubmed/37630512 http://dx.doi.org/10.3390/microorganisms11081953 |
Ejemplares similares
-
Use of Remdesivir in Patients with SARS-CoV-2 Pneumonia in a Real-Life Setting during the Second and Third COVID-19 Epidemic Waves
por: Marocco, Raffaella, et al.
Publicado: (2023) -
Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection
por: Mascia, Claudia, et al.
Publicado: (2018) -
Systemic, Mucosal Immune Activation and Psycho-Sexual Health in ART-Suppressed Women Living with HIV: Evaluating Biomarkers and Environmental Stimuli
por: Nijhawan, Parni, et al.
Publicado: (2023) -
Longitudinal Assessment of Multiple Immunological and Inflammatory Parameters during Successful DAA Therapy in HCV Monoinfected and HIV/HCV Coinfected Subjects
por: Zuccalà, Paola, et al.
Publicado: (2022) -
Effectiveness, Tolerability and Prescribing Choice of Antiviral Molecules Molnupiravir, Remdesivir and Nirmatrelvir/r: A Real-World Comparison in the First Ten Months of Use
por: Del Borgo, Cosmo, et al.
Publicado: (2023)